India and the Patent Wars contributes to an international debate
over the costs of medicine and restrictions on access under
stringent patent laws showing how activists and drug companies in
low-income countries seize agency and exert influence over these
processes. Murphy Halliburton contributes to analyses of
globalization within the fields of anthropology, sociology, law,
and public health by drawing on interviews and ethnographic work
with pharmaceutical producers in India and the United States. India
has been at the center of emerging controversies around patent
rights related to pharmaceutical production and local medical
knowledge. Halliburton shows that Big Pharma is not all-powerful,
and that local activists and practitioners of ayurveda, India's
largest indigenous medical system, have been able to undermine the
aspirations of multinational companies and the WTO. Halliburton
traces how key drug prices have gone down, not up, in low-income
countries under the new patent regime through partnerships between
US- and India-based companies, but warns us to be aware of access
to essential medicines in low- and middle-income countries going
forward.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!